Register Login
Register to leave comments
  • News bot Aug. 13, 2026, 12:36 p.m.

    📋 PULMATRIX, INC. (PULM) - Financial Results

    Filing Date: 2026-08-13

    Accepted: 2026-08-13 08:15:11

    Event Type: Financial Results

    Event Details:

    PULMATRIX, INC. (PULM) Reports the reporting period Financial Results PULMATRIX, INC. (PULM) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: Not disclosed
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 2168
      • targeting mitochondrial dysfunction in aging-related diseases using the MitoXcel™ platform. To that end, we have filed a Form S-4 in relation to the Merger.” Proposed Merger with Eos SENOLYTIX As previously reported, on March 26, 2026

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2026 2025 Change ($) Change (%)
    Current Assets Prepaid Expenses Other Current Assets 371.00 41.00 $330.00 +804.88%
    Current Liabilities Accounts Payable 529.00 272.00 $257.00 +94.49%
    Operating Expenses Loss From Operations 1.55K 2.34K $-790.00 -33.79%
    Other Income Expense Interest Income 41.00 22.00 $19.00 +86.36%
    Other Income Expense Total Other Income Expense 1.00 130.00 $-129.00 -99.23%
    Other Income Expense Net Loss 1.55K 2.21K $-659.00 -29.85%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: PULMATRIX, INC.
    • Ticker Symbol: PULM

Search

News categories